| Videos | Channels | Search |
Discovery from public oncological data using QIAGEN Omicsoft OncoLand and QIAGEN Ingenuity Pathway Analysis - June 17 2021
In this 90-minute training, we will discuss how to discover and validate biomarkers as well as drug targets and key genes using public oncological data from GEO, TCGA, CCLE and other sources. To do this, we will use QIAGEN Omicsoft OncoLand, QIAGEN Ingenuity Pathway Analysis (IPA) and the OmicSoft Land Explorer web interface.
Specifically, for conditions of interest (diseases, cell lines, treatments etc.), we will discuss how to:
• Identify public studies of interest
• Derive a biomarker/gene signature
• Study expression of a gene or drug target
• Correlate expression of multiple genes and biomarkers
• Visualize a gene signature in the context of a heatmap
• Compare public data with other public data or a user’s own data
Speaker: Sumana Chintalapudi, Ph.D., Field Application Scientist, QIAGEN Digital Insights
01:14:49 minutes
Tags: discovery, english, ipa webinar, land explorer, omicsoft, omicsoft webinar